Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report
Authored by
Andy Pan
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada, Department of Emergency Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada and Division of Critical Care Medicine, Hôpital Montfort, Ottawa, Ontario, Canada.
Imran Khan
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada, School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada and Institut du Savoir Montfort, Hôpital Montfort, Ottawa, Ontario, Canada.
Marlene Mansour
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada and Division of Critical Care Medicine, Hôpital Montfort, Ottawa, Ontario, Canada.
Bernadett Kovacs
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada, Division of Critical Care Medicine, Hôpital Montfort, Ottawa, Ontario, Canada and Institut du Savoir Montfort, Hôpital Montfort, Ottawa, Ontario, Canada.
Caitlin Richler
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada and School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Christine Landry
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada, School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada and Institut du Savoir Montfort, Hôpital Montfort, Ottawa, Ontario, Canada.
Kimberley Do
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada, School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada and Institut du Savoir Montfort, Hôpital Montfort, Ottawa, Ontario, Canada.
Sydney Morin
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada and School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Deb Purkayastha
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada and School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Melissa Varsava
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada and School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Emma Baun
Programme de Pharmacie, Université de Lyon, Lyon, France.
Pierre Thabet
Department of Pharmacy, Hôpital Montfort, Ottawa, Ontario, Canada, School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Ontario, Canada and Institut du Savoir Montfort, Hôpital Montfort, Ottawa, Ontario, Canada.